$CBRS

Restructuring shifts nearly 1M Cerebras (CBRS) shares

Cerebras Systems Inc. (CBRS) director Susan Lior reported restructuring-related transfers of 996K Class A shares on September 2, 2026. The shares were distributed from Eclipse-affiliated funds to her directly and to an estate-planning vehicle she controls. She now holds 290,661 shares directly and additional shares indirectly.

Original reporting
Published Sep 4, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 5, 2026, 4:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

Provides transparency on insider ownership but unlikely to drive price.

02

Market read

Primary insider filing with modest materiality; limited trading relevance.

03

What to watch

Potential future voting power changes due to estate vehicle holdings.

Relevance 4/10Novelty 4/10Timing: post-filing Sep 2 2026

Background

Form 4 filing details insider share movements for Cerebras Systems.

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Director Susan Lior disclosed a non-cash transfer of 996,000 Cerebras shares via in-kind distribution on Sep 2, 2026.

Expected impact

Minimal short-term movement; market may view as neutral.

Evidence & confidence

Insider transfers of this size are material for ownership tracking but lack cash proceeds, reducing trading urgency.

Market effects

None significant for AI hardware sector.

Limited to US-listed AI chip stocks.

Low

Counterpoint

Some investors may view the transfer as a signal of confidence by the director, prompting a modest buy.

Key entities

  • Susan Lior

    Cerebras Systems Inc. director reporting insider share transfers.

Related articles

$CBRSMedAI 8/10

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.

$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.

$CBRSMed

CBRS Stock Slides As Cerebras Ramps AI Capacity And Growth

Cerebras Systems Inc. (CBRS) stock rose 10.73% on September 4, 2026, driven by investor optimism around AI chip adoption. The company reported Q2 2026 revenue of $510M and a loss of $451M, with a high price-to-sales multiple of 117x. Morgan Stanley reiterated its overweight rating, citing strong AI demand and partnerships. CBRS faces execution risks due to high spending on AI capacity expansion.

$CBRSMed

Cerebras Systems Stock Slides As Wall Street Backs Aggressive AI Expansion

Cerebras Systems Inc. (CBRS) stock rose 10.91% on September 4, 2026, driven by bullish sentiment around its AI chip advancements. The company reported quarterly revenue of $180.1M and a net loss of $450.5M, with a price-to-sales ratio of 117.36. Morgan Stanley reiterated its overweight rating, citing surging AI inference demand and expected revenue growth. However, risks include execution challenges in data center expansion and profitability concerns.

$CBRSMed

Cerebras Stock Jumps 12% as Finland Capacity Tests a $51 Billion Valuation

Cerebras Systems (CBRS) shares rose 12% to $213.26, nearing a $51B valuation. The surge followed a Finland data-center contract announcement, with plans for 50MW, 80MW, and 165MW stages. The stock initially fell 6.3% on the news but recovered. Cerebras has $8.6B in cash and $25.4B in performance obligations, with a 2026 revenue forecast of $880M-$890M.

$CBRSHighAI 8/10

Why is Cerebras Systems stock surging today?

Cerebras Systems stock rose 6.4% to $202.61 after announcing a 165 MW AI data center in Finland, partnering with Compute Nordic Finland. The company reported Q2 2026 revenue of $209.9M, beating estimates, and raised full-year guidance to $880M-$890M. Analysts and ARK Invest have shown support.